麻豆国产精品一二三在线观-麻豆国产精品一二三在线观看-麻豆国产精品一区二区-麻豆国产精品永久免费视频-麻豆国产巨作av剧情-麻豆国产蜜桃臀视频在线观看

英國Thermo Fisher Oxoid???
英國Oxoid于1924年成立，現屬于知名的Thermo Fisher Scientific集團一員，目前為領先全球的微生物培養基制造商與診斷試劑銷售商。公司總部位于英國貝星斯托克(Basingstoke)，產品銷售遍及歐盟各國、美洲與澳洲，另外也委托世界各地專業的微生物產品代理商經營國際Oxoid事業。Oxoid產品范圍闊及與疾病、微生物診斷相關的臨床檢驗科學、基礎學術研究與工業生產領域。
英國Oxoid是世界上第二大微生物相關產品的生產商，總部設在英格蘭Basingstoke，在全球14個國家設有分公司，并在62個國家和地區設有經授權的代理商。
Oxoid培養基、微生物培養、診斷試劑、生化鑒定、藥敏紙錠
?
Oxoid (part of Thermo Fisher Scientific) is one of the world's leading manufacturers and distributors of microbiological culture media and other diagnostic products. The corporate headquarters in Basingstoke, Hampshire is the main production and administrative site, supported by a network of wholly owned sales and distribution companies in Europe, North and South America and Australia. Many other countries are supplied through specialist distributors. The Oxoid range of products is used in clinical and industrial laboratories to isolate and identify the bacteria or other organisms causing disease or spoilage.

People
A key feature in the success of Oxoid over its long history has been the skill and knowledge of its staff. Emphasis is placed on the recruitment and retention of experienced scientists with a background in Microbiology for Sales and Marketing jobs as well as in the laboratory based R & D and Quality departments. Professionally qualified staff are also essential to the operation and as is constant improvement of our Manufacturing, Engineering, Accounting and Information Systems departments. Staff is encouraged to obtain formal qualifications or continue to develop their vocational and managerial skills. In total the Oxoid Group employs c.970 staff in 17 countries. In the UK there are around 620 people, mainly based in Basingstoke, but also within its subsidiary sites in Perth, Scotland (G&M Procter), Dartford (Remel Europe) and Oxoid (Ely) Ltd.

Production Facilities
The Basingstoke factory is responsible for the manufacture of Peptones (key ingredients in culture media made by enzymatic or acid hydrolysis of proteins), Dehydrated Culture Media, Antimicrobial Susceptibility Tests (used to decide which antibiotics will provide an effective treatment for a patient with a microbial infection) and a range of other microbiological and immunological tests and products. This necessitates the use of a wide range of production techniques and equipment capable of handling tonne quantities of peptone down to micrograms of antibody. Specialist equipment includes freeze driers, sterile filling lines and clean rooms, vacuum ovens, evaporators and spray driers.

A large scale and ongoing investment in the integration of the Supply Chain using the SAP enterprise resource planning system is being used, together with the training and development of staff, to achieve world class manufacturing capabilities.

Oxoid is a major supplier of ready prepared media for the health, food and pharmaceutical markets and has its own production facilities in Perth, Scotland; Wesel, Germany; Ottawa, Canada; and, as a result of an acquisition in September 2003, in Adelaide, Australia. These units contain sophisticated preparators and pouring lines in carefully controlled environments which ensure consistent products are made to international standards. Investment continued with the completion of our new factory in Perth, which began production in May 2004.

Quality
A rigorous Quality Assurance and Quality Control system ensures that customers receive products meeting the technical specifications and regulatory standards required. This is backed up by the ISO 9000 registration held by Oxoid since 1990 and additional registration to ISO 13485 for medical devices since 2004.

Product Development
Although many traditional culture media have been in use for a considerable time and remain an important part of the range, Oxoid continues to introduce new products in order to improve and speed up the process of isolating organisms from clinical, food or other sources. Changes in eating habits, food production methods and to the environment have led to the increased importance of such organisms as Listeria, E.coli O157, Salmonella and Legionella. Oxoid products developed to detect these organisms are an important part of public health.

Products launched recently include a range of chromogenic media for food pathogens; Oxoid Aura Image - an automated zone reader for susceptibility testing of clinical specimens; O.B.I.S. - a range of biochemical identification systems. Oxoid is also the distributor in Europe and Australia for the BAX system of PCR assays for microbial screening of food samples.

Historical Background
The origins of Oxoid go back into the 19th Century when the science of bacteriology was also beginning. The original parent company, the Liebig Extract of Meat Company (Lemco) manufactured meat extracts which could conveniently be used in laboratories to grow bacteria. Liebigs produced a popular - and cheaper - version of meat extract around the turn of the century and named it Oxo, with the familiar Oxo cube following a few years later.

The Oxoid name was first used in 1924 to brand glandular extracts and other products sold to hospitals and laboratories. By the 1950s modern pharmaceuticals had replaced the earlier glandular extracts in the treatment of patients and the Oxoid brand became synonymous with dehydrated culture media. In 1965 this had grown to the point where, rather than being just the Medical Division of Oxo, Oxoid Limited was set up as a separate company in the Liebig group.

During 1968 Liebig merged with Brooke Bond and in 1975 Oxoid left the Oxo cube factory in Southwark, London where the company had been founded and moved to new purpose-built facilities in Basingstoke. Also at this time a number of subsidiaries were set up in Europe, Canada and Australia.

In 1984 the Brooke Bond group was acquired by Unilever and Oxoid became part of their Medical Products group, later merging with Unipath a diagnostics company then developing pregnancy tests and other similar products for the consumer market. Both parts of the new company continued to grow, adding more subsidiaries and developing immunological products for the microbiology market.

By 1996 Unilever had decided to concentrate on consumer products resulting in the separating of the Unipath and Oxoid businesses. Oxoid, following a management buy-out, became an independent company at the beginning of 1997. Unilever's other Speciality Chemical companies were sold to ICI. In July 2000 PPMVentures, a subsidiary of Prudential Plc, became the major shareholder in Oxoid.

In February 2004, Fisher Scientific International acquired Oxoid and, following Fisher's acquisition of Apogent later that year, brought Oxoid together with Remel Inc. to form a specialist Microbiology division.

Fisher Scientific International merged with Thermo Electron Corporation on 9th November 2006 to form Thermo Fisher Scientific.

Continued expansion through new subsidiaries and novel products had remained the major a